Sanofi's 'next-generation' COVID-19 booster outperformed traditional boosters
Marketwatch -

Sanofi said Monday that preliminary data shows that its experimental next-generation COVID-19 booster provided a 40-fold increase in antibody protection against BA.1, a subvariant of omicron, in adults who had been previously vaccinated with the mRNA shots. Next-generation vaccines and boosters are based on newer variants of SARS-CoV-2, compared with the currently available vaccines, which were designed to protect against the original strain of the virus first detected in 2019. Sanofi's...

Related Articles

Latest in Finance

More from Marketwatch | article_normal SNY GSK BNTX PFE SPX